Who Should Consider GLP-1 Treatment and Important Safety Considerations GLP-1 treatment for menopause weight gain is most appropriate for women with BMI 27 and metabolic complications (insulin resistance, hypertension, dyslipidemia) or those struggling with appetite control despite adequate nutrition and activity
pAAV-hSyn-EGFP, plasmid from Addgene, 50465-AAV8, RRID: Addgene_50465-AAV8, virus packaged at UNC Vector Core (100 l at titre 7 10 12 vg ml 1 ), retroAAV2-EF1a-oNLS-oScarlet 52 (100 l at titre 3 10 13 vg ml 1 )), was delivered using a glass pipette at a flow rate of 50 nl per min driven by a microsyringe pump controller (World Precision Instruments, model Micro 4) per targeted site
However, for Retatrutide and Tirzepatide, once weekly is the standard that optimizes consistency and practical application in research
Heart rate elevation Tirzepatide causes a modest average increase in heart rate of 2-4 beats per minute
Dpp4 EC+/+ (BMT) ( E and F , n = 68/group for TG, n = 46 for other groups), and Dpp4 Gut/ vs